{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:23:19Z","timestamp":1793064199096,"version":"4.5.0"},"reference-count":32,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"2","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO"],"published-print":{"date-parts":[[2021,1,10]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>\n                      <jats:sup>18<\/jats:sup>\n                      F-Fluorodeoxyglucose (FDG) positron emission tomography (PET)\/computed tomography (CT) is currently the standard technique to define minimal residual disease (MRD) status outside the bone marrow (BM) in patients with multiple myeloma (MM). This study aimed to define criteria for PET complete metabolic response after therapy, jointly analyzing a subgroup of newly diagnosed transplantation-eligible patients with MM enrolled in two independent European randomized phase III trials (IFM\/DFCI2009 and EMN02\/HO95).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS AND METHODS<\/jats:title>\n                    <jats:p>Two hundred twenty-eight patients were observed for a median of 62.9 months. By study design, PET\/CT scans were performed at baseline and before starting maintenance (premaintenance [PM]). The five-point Deauville scale (DS) was applied to describe BM (BM score [BMS]) and focal lesion (FL; FL score [FS]) uptake and tested a posteriori in uni- and multivariable analyses for their impact on clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>At baseline, 78% of patients had FLs (11% extramedullary), 80% with an FS \u2265 4. All patients had BM diffuse uptake (35.5% with BMS \u2265 4). At PM, 31% of patients had visually detectable FLs (2% extramedullary), 24% and 67.7% of them with an FS of 3 and \u2265 4, respectively. At PM, 98% of patients retained residual BM diffuse uptake, which was significantly lower than at baseline (mainly between BMS 2 and 3, BMS was \u2265 4 in only 8.7% of patients). By both uni- and multivariable analysis, FS and BMS &lt; 4 were associated with prolonged progression-free survival (PFS) and overall survival (OS) at PM (OS: hazard ratio [HR], 0.6 and 0.47, respectively; PFS: HR, 0.36 and 0.24, respectively)<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>FL and BM FDG uptake lower than the liver background after therapy was an independent predictor for improved PFS and OS and can be proposed as the standardized criterion of PET complete metabolic response, confirming the value of the DS for patients with MM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/jco.20.00386","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T15:59:56Z","timestamp":1604591996000},"page":"116-125","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":146,"title":["Standardization of\n                    <sup>18<\/sup>\n                    F-FDG\u2013PET\/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma"],"prefix":"10.1200","volume":"39","clinical-trial-number":[{"clinical-trial-number":"nct01134484","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01309334","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1422-7305","authenticated-orcid":false,"given":"Elena","family":"Zamagni","sequence":"first","affiliation":[{"name":"\u201cSeragnoli\u201d Institute of Hematology, Bologna University School of Medicine, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Nanni","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, L\u2019Azienda Ospedaliero-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Dozza","sequence":"additional","affiliation":[{"name":"\u201cSeragnoli\u201d Institute of Hematology, Bologna University School of Medicine, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6932-7322","authenticated-orcid":false,"given":"Thomas","family":"Carlier","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Nantes University Hospital, CRCINA INSERM, CNRS, Universit\u00e9 d'Angers, Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Bailly","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Nantes University Hospital, CRCINA INSERM, CNRS, Universit\u00e9 d'Angers, Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Tacchetti","sequence":"additional","affiliation":[{"name":"\u201cSeragnoli\u201d Institute of Hematology, Bologna University School of Medicine, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annibale","family":"Versari","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, AUSL-IRCSS of Reggio Emilia, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4394-5031","authenticated-orcid":false,"given":"Stephane","family":"Chauvie","sequence":"additional","affiliation":[{"name":"Medical Physics Unit, Santa Croce e Carle Hospital, Cuneo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2054-7412","authenticated-orcid":false,"given":"Andrea","family":"Gallamini","sequence":"additional","affiliation":[{"name":"Research and Innovation Department, Antoine Lacassagne Cancer Center, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3616-5838","authenticated-orcid":false,"given":"Barbara","family":"Gamberi","sequence":"additional","affiliation":[{"name":"Hematology Unit, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Caillot","sequence":"additional","affiliation":[{"name":"Hematology Department, University Hospital, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Patriarca","sequence":"additional","affiliation":[{"name":"Hematology, Dipartimento di Area Medica, Udine University, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Macro","sequence":"additional","affiliation":[{"name":"Hematology Department, University Hospital, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Boccadoro","sequence":"additional","affiliation":[{"name":"Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Garderet","sequence":"additional","affiliation":[{"name":"Hematology Department, University Hospital, Piti\u00e9 Salp\u00e9triere, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7828-8230","authenticated-orcid":false,"given":"Simona","family":"Barbato","sequence":"additional","affiliation":[{"name":"\u201cSeragnoli\u201d Institute of Hematology, Bologna University School of Medicine, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fanti","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, L\u2019Azienda Ospedaliero-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0131-8689","authenticated-orcid":false,"given":"Aurore","family":"Perrot","sequence":"additional","affiliation":[{"name":"Hematology Department, University Hospital, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8619-412X","authenticated-orcid":false,"given":"Francesca","family":"Gay","sequence":"additional","affiliation":[{"name":"Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0808-2237","authenticated-orcid":false,"given":"Peter","family":"Sonneveld","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Karlin","sequence":"additional","affiliation":[{"name":"Hematology Department, University Hospital, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Cavo","sequence":"additional","affiliation":[{"name":"\u201cSeragnoli\u201d Institute of Hematology, Bologna University School of Medicine, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bodet-Milin","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Nantes University Hospital, CRCINA INSERM, CNRS, Universit\u00e9 d'Angers, Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moreau","sequence":"additional","affiliation":[{"name":"Hematology Department, University Hospital, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Kraeber-Bod\u00e9r\u00e9","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Nantes University Hospital, CRCINA INSERM, CNRS, Universit\u00e9 d'Angers, Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26467"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30189-4"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-825356"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-361386"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-213280"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.72.2975"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-451690"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0396"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30206-6"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00296-y"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-842880"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611750"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-017-3909-8"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2961-x"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.104125"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/10428190903040048"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404284"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2307\/2532740"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.100784"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.078519"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e31825b2071"},{"key":"B26","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1182\/blood.V122.21.1696.1696","volume":"122","author":"Ghimire K","year":"2013","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.177139"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2014.09.012"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-774422"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.217539"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2018.02.009"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/52759767"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14401"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13131529"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019181949"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.20.00386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T03:45:37Z","timestamp":1653795937000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.20.00386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,10]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1,10]]}},"alternative-id":["10.1200\/JCO.20.00386"],"URL":"https:\/\/doi.org\/10.1200\/jco.20.00386","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,10]]},"assertion":[{"value":"2020-10-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}